<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "ECOG_performance_status.v1",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "sv": {
      "name": "ECOG Funktionsstatus",
      "description": "Funktionsstatus (Performance Status) enligt Eastern Cooperative Oncology Group"
    },
    "en": {
      "name": "ECOG Performance Status",
      "description": "The Eastern Cooperative Oncology Group Scale of Performance Status"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-06-19",
      "name": "Eneimi Allwell-Brown",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "otherContributors": [
      "Dennis Forslund, Cambio Healthcare Systems"
    ],
    "details": {
      "sv": {
        "purpose": "Att utvärdera funktionellt status hos en patient med aktiv cancersjukdom, inklusive allmän daglig livsföring (ADL).",
        "keywords": [
          "Zubrod score",
          "WHO performance status",
          "Karnofsky index",
          "cancer",
          "ECOG",
          "onkologi",
          "KPS",
          "PPS",
          "WHO",
          "WHO funktionsstatus"
        ],
        "use": "Att registrera en patients funktionsstatus i enlighet med ECOG. Baselinevärdering bör genomföras vid initial kontakt, och inför initierad behandling.\n\nFunktionsstatus enligt ECOG är en viktig prognostisk indikator och används för att värdera en patients funktionsnivå, effektivitet och lämplighet av behandling, samt sjukdomsprogression. Det är särskilt användbart för studier på patienter som genomför cellgiftsbehandling.\n\nFunktionsstatus enligt ECOG:\n0 \u003d Klarar all normal aktivitet utan begränsning. \n1 \u003d Klarar inte fysiskt krävande aktivitet men är uppegående och klarar lättare arbete. \n2 \u003d Är uppegående och kan sköta sig själv men klarar inte att arbeta. Är uppe och i\nrörelse mer än 50 % av dygnets vakna timmar. \n3 \u003d Kan endast delvis sköta sig själv. Är bunden till säng eller stol mer än 50 % av\ndygnets vakna timmar. \n4 \u003d Klarar inte någonting. Kan inte sköta sig själv. Är bunden till säng eller stol. \n5 \u003d Död.\nEn nedgradering om ≥1 bedöms innebära sjukdomsprogression.\n\nKategorierna kan översättas till Karnofsky Performance Status (KPS) och Palliative Performance Scale (PPS), enligt:\n\nECOG          PPS                        KPS\n0                   100                        100—Normal funktion, inga inskränkningar; inga sjukdomstecken\n                       \n1                     90                          90—Fortsatt normalfungerande; mindre tecken eller symptom på sjukdom\n                       80                          80—Normal funktion med ansträngning; vissa tecken eller symptom på sjukdom\n                       \n2                     70                          70—Klarar egenvård men oförmögen att upprätthålla normal funktion eller genomföra aktivt jobb\n                       60                          60—Kräver sporadiskt assistans men kan för det mesta klara egenvård\n                       \n3                     50                          50—Kräver omfattande assistans och frekvent vård\n                       40                          40—Handikappad; kräver specialiserad vård och assistans\n                       \n4                     30                          30—Svårt handikappad; vård på inrättning indicerad, död ej nära förestående\n                       20                          20—Svårt sjuk; sjukhusvård och aktivt stödjande vård nödvändig\n                       10                          10—Döende\n\n5                       0                            0—Död\n",
        "misuse": "Funktionsstatus enligt ECOG ska endast bedömas av läkare, och ska ej baseras på patientens egna värdering.",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "purpose": "To assess the functional status of a patient with cancerous disease, and their ability to perform activities of daily living.",
        "keywords": [
          "Zubrod score",
          "WHO performance status score",
          "Karnofsky index",
          "cancer prognosis",
          "ECOG-ACRIN",
          "ECOG score",
          "KPS",
          "PPS",
          "oncology"
        ],
        "use": "To record the ECOG performance status score of a patient, as assessed by a clinician. The reference recording should be performed at initial presentation and before the implementation of treatment. ECOG performance status is an important prognostic indicator and is used to determine the level of functioning of the patient, the effectiveness and appropriateness of treatment, and to assess disease progression. It is particularly useful for cancer clinical researchers while enrolling patients for chemotherapy trials, as it helps ensure uniformity in patient selection in addition to tracking changes in a patient’s level of functioning as a result of treatment during the trial.\nECOG score is graded from 0 (zero) to 5 (five):\n0 \u003d Fully active, able to carry on all pre-disease performance without restriction\n1 \u003d Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work\n2 \u003d Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours\n3 \u003d Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours\n4 \u003d Completely disabled; cannot carry on any selfcare; totally confined to bed or chair\n5 \u003d Dead\nA deterioration in ECOG performance status of ≥1 is regarded as disease progression. \n\nThe 6 grades of ECOG performance status have been mapped to the also popular Karnofsky Performance Status (KPS) and Palliative Performance Scale (PPS).\nECOG          PPS                        KPS\n0                   100                        100—Normal, no complaints; no evidence of disease\n                       \n1                     90                          90—Able to carry on normal activity; minor signs or symptoms of disease\n                       80                          80—Normal activity with effort, some signs or symptoms of disease\n                       \n2                     70                          70—Cares for self but unable to carry on normal activity or to do active work\n                       60                          60—Requires occasional assistance but is able to care for most of personal needs\n                       \n3                     50                          50—Requires considerable assistance and frequent medical care\n                       40                          40—Disabled; requires special care and assistance\n                       \n4                     30                          30—Severely disabled; hospitalization is indicated although death not imminent\n                       20                          20—Very ill; hospitalization and active supportive care necessary\n                       10                          10—Moribund\n\n5                       0                            0—Dead",
        "misuse": "ECOG score is only to be determined by a clinician, and not from a patients\u0027 own notes.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American journal of clinical oncology. 1982 Dec 1;5(6):649-56.\n\n2. Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases. 1960 Jan 1;11(1):7-33.\n\n3. Ma C, Bandukwala S, Burman D, Bryson J, Seccareccia D, Banerjee S, Myers J, Rodin G, Dudgeon D, Zimmermann C. Interconversion of three measures of performance status: an empirical analysis. European Journal of Cancer. 2010 Dec 31;46(18):3175-83."
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "ECOG_performance_status.v1"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "sv": {
      "id": "sv",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "Referenser"
        }
      }
    },
    "en": {
      "id": "en",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "References"
        }
      }
    }
  },
  "resultTemplates": []
}</script></head><body></body></html>